Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)

3.23
Delayed Data
As of 4:00pm ET
 -0.06 / -1.82%
Today’s Change
2.40
Today|||52-Week Range
5.88
-16.10%
Year-to-Date
No recent news for AcelRx Pharmaceuticals Inc.

Today’s Trading

Previous close3.29
Today’s open3.31
Day’s range3.16 - 3.31
Volume178,683
Average volume (3 months)317,602
Market cap$149.1M
Dividend yield--
Data as of 4:00pm ET, 08/30/2016

Growth & Valuation

Earnings growth (last year)+34.07%
Earnings growth (this year)-49.67%
Earnings growth (next 5 years)+46.60%
Revenue growth (last year)+269.24%
P/E ratioNM
Price/Sales8.89
Price/Book4.50

Competitors

 Today’s
change
Today’s
% change
CARACara Therapeutics In...-0.03-0.45%
SYNSynthetic Biologics ...-0.02-1.20%
CLSDClearside Biomedical...+0.33+4.62%
ADHDAlcobra Ltd-0.18-3.40%
Data as of 4:00pm ET, 08/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$19.3M
Annual profit (last year)-$24.4M
Net profit margin-126.66%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Howard B. Rosen
CFO &
Head-Business Development
Timothy E. Morris
Corporate headquarters
Redwood City, California

Forecasts

Search for Jobs